Related references
Note: Only part of the references are listed.The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics
Gargi Dixit et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2022)
In Vivo Effects of Prostaglandin Analogues Application by Topical Drops or Retrobulbar Injections on the Orbital Fat of a Rat Model
Doha Jbara et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2022)
Mitophagy: Molecular Mechanisms, New Concepts on Parkin Activation and the Emerging Role of AMPK/ULK1 Axis
Roberto Iorio et al.
CELLS (2022)
Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?
Luca D'andrea et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Ocular benzalkonium chloride exposure: problems and solutions
Michael H. Goldstein et al.
EYE (2022)
Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells
Sabrina Petricca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets
Gulgun Tezel
PROGRESS IN RETINAL AND EYE RESEARCH (2022)
Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma
Mariaelena Filippelli et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Multi-Target Effects of ss-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation
Roberto Iorio et al.
ANTIOXIDANTS (2022)
Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research
Xianbo Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Lactobacillus sakei Pro-Bio65 Reduces TNF-α Expression and Upregulates GSH Content and Antioxidant Enzymatic Activities in Human Conjunctival Cells
Roberto Iorio et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)
Targeting the NLRP3 Inflammasome in Glaucoma
Sophie Coyle et al.
BIOMOLECULES (2021)
Cyclic and Acyclic Amine Oxide Alkyl Derivatives as Potential Adjuvants in Antimicrobial Chemotherapy against Methicillin-Resistant Staphylococcus aureus with an MDR Profile
Lorenza Fagnani et al.
ANTIBIOTICS-BASEL (2021)
Time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002%: a pilot, comparative study versus ripasudil 0.4%
Etsuko Terao et al.
BMJ OPEN OPHTHALMOLOGY (2020)
Tebuconazole and Econazole Act Synergistically in Mediating Mitochondrial Stress, Energy Imbalance, and Sequential Activation of Autophagy and Apoptosis in Mouse Sertoli TM4 Cells: Possible Role of AMPK/ULK1 Axis
Sabrina Petricca et al.
TOXICOLOGICAL SCIENCES (2019)
Mitochondrial membrane potential
Ljubava D. Zorova et al.
ANALYTICAL BIOCHEMISTRY (2018)
2017 FDA drug approvals The FDA approved 46 new drugs last year, the highest total in more than two decades
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2018)
In Vivo Effects of Retrobulbar Bimatoprost Injection on Orbital Fat
Kian Eftekhari et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2018)
Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2
David E. Sanin et al.
IMMUNITY (2018)
Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis
Juan J. Moreno
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Sandipan Datta et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Apoptotic effects of bovine apo-lactoferrin on HeLa tumor cells
Carla Luzi et al.
CELL BIOCHEMISTRY AND FUNCTION (2017)
Mitochondrial dynamics during cell cycling
Rostyslav Horbay et al.
APOPTOSIS (2016)
Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Rossella Russo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions
Inmaculada Martinez-Reyes et al.
MOLECULAR CELL (2016)
Effect of topical prostaglandin analogues on corneal hysteresis
Gema Bolivar et al.
ACTA OPHTHALMOLOGICA (2015)
Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro
Angelica Maria de Sousa Leal et al.
BMC MICROBIOLOGY (2015)
Mancozeb affects mitochondrial activity, redox status and ATP production in mouse granulosa cells
Roberto Iorio et al.
TOXICOLOGY IN VITRO (2015)
Mitochondrial hyperpolarization during chronic complex I inhibition is sustained by low activity of complex II, III, IV and V
Marleen Forkink et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2014)
Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients
M. Figus et al.
EYE (2014)
ELF-MF attenuates quercetin-induced apoptosis in K562 cells through modulating the expression of Bcl-2 family proteins
Fabrizia Brisdelli et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study)
Heidi Cate et al.
BMC OPHTHALMOLOGY (2014)
Localisation and quantification of benzalkonium chloride in eye tissue by TOF-SIMS imaging and liquid chromatography mass spectrometry
Nicolas Desbenoit et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
Fluctuating vs. Continuous Exposure to H2O2: The Effects on Mitochondrial Membrane Potential, Intracellular Calcium, and NF-κB in Astroglia
Aleksandar Bajic et al.
PLOS ONE (2013)
Mitochondria as a Target of Environmental Toxicants
Joel N. Meyer et al.
TOXICOLOGICAL SCIENCES (2013)
How Ocular Surface Disease Impacts the Glaucoma Treatment Outcome
Snjezana Kastelan et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Comparison of the Long-Term Effects of Various Topical Antiglaucoma Medications on Meibomian Glands
Reiko Arita et al.
CORNEA (2012)
Effects of long-term topical anti-glaucoma medications on meibomian glands
Reiko Arita et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
A New Safety Concern for Glaucoma Treatment Demonstrated by Mass Spectrometry Imaging of Benzalkonium Chloride Distribution in the Eye, an Experimental Study in Rabbits
Francoise Brignole-Baudouin et al.
PLOS ONE (2012)
Involvement of Mitochondrial Activity in Mediating ELF-EMF Stimulatory Effect on Human Sperm Motility
Roberto Iorio et al.
BIOELECTROMAGNETICS (2011)
Mitochondrial disorders and the eye
Samantha A. Schrier et al.
CURRENT OPINION IN OPHTHALMOLOGY (2011)
Effects of Common Topical Antiglaucoma Medications on the Ocular Surface, Eyelids and Periorbital Tissue
J. Javier Servat et al.
DRUGS & AGING (2011)
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost
Juwan Park et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2011)
Efficacy and Safety of Switching from Topical Latanoprost to Bimatoprost in Patients with Normal-Tension Glaucoma
Shino Sato et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2011)
Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature
Sayime Aydin et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2010)
A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma
A. C. S. How et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Bimatoprost-Induced Calcium Signaling in Human T-Cells does not Involve Prostanoid FP or TP Receptors
June Chen et al.
CURRENT EYE RESEARCH (2009)
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4
R. D. Williams et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Efficacy and Tolerability of Prostaglandin Analogs A Meta-analysis of Randomized Controlled Clinical Trials
Florent Aptel et al.
JOURNAL OF GLAUCOMA (2008)
Periorbital changes associated with topical bimatoprost
Theodoros Filippopoulos et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
Electrophysiological characterization of tight junctional pathway of rabbit cornea treated with ophthalmic ingredients
Tadahiro Nakamura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Effects of bimatoprost 0.03% on ocular hemodynamics in normal tension glaucoma
Mei-Ju Chen et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma
Monte S. Dirks et al.
ADVANCES IN THERAPY (2006)
PGE(2)-induced apoptotic cell death in k562 human leukaemia cells
Michael Foeller et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2006)
Allergic reaction to topical eyedrops
C Baudouin
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2005)
The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases
B Kadenbach et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2004)
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension
JS Cohen et al.
SURVEY OF OPHTHALMOLOGY (2004)
Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: Results from parallel-group comparison trials
ST Simmons et al.
ADVANCES IN THERAPY (2004)
Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity
A Perl et al.
TRENDS IN IMMUNOLOGY (2004)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mitochondria: Releasing power for life and unleashing the machineries of death
DD Newmeyer et al.
CELL (2003)
Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension
RM Feldman
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2003)
Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells
NA Sharif et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2003)
Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects
WC Stewart et al.
JOURNAL OF GLAUCOMA (2003)
The efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medications
EJ Higginbotham et al.
SURVEY OF OPHTHALMOLOGY (2002)